Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120
- PMID: 9491908
- DOI: 10.1089/aid.1998.14.191
Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120
Abstract
The binding of a panel of monoclonal antibodies to V1, V2, and V3 loop-deleted HIV-1 gp120 was studied by competition analysis. Most of the previously defined relationships between gp120 epitopes were preserved on the variable loop-deleted protein, although interactions between some epitopes were dependent on the presence of the V1, V2, and V3 loops. Enzymatic deglycosylation of the variable loop-deleted protein only minimally altered the binding of most antibodies examined. Thus, a carbohydrate-deficient, conserved HIV-1 gp120 core can be produced that has a structure closely approximating that of the full-length, correctly folded gp120 monomer.
Similar articles
-
Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.J Virol. 1995 Sep;69(9):5723-33. doi: 10.1128/JVI.69.9.5723-5733.1995. J Virol. 1995. PMID: 7543586 Free PMC article.
-
A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.J Virol. 2003 Jun;77(12):6965-78. doi: 10.1128/jvi.77.12.6965-6978.2003. J Virol. 2003. PMID: 12768015 Free PMC article.
-
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.J Immunol. 1995 Jan 15;154(2):893-906. J Immunol. 1995. PMID: 7529290
-
Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies.Virology. 2003 Jan 5;305(1):124-37. doi: 10.1006/viro.2002.1727. Virology. 2003. PMID: 12504547
-
[Role of the HIV-1 gp120 V1/V2 domains in the induction of neutralizing antibodies].Enferm Infecc Microbiol Clin. 2009 Nov;27(9):523-30. doi: 10.1016/j.eimc.2008.02.010. Epub 2009 May 1. Enferm Infecc Microbiol Clin. 2009. PMID: 19409660 Review. Spanish.
Cited by
-
Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.J Virol. 2003 Dec;77(23):12782-94. doi: 10.1128/jvi.77.23.12782-12794.2003. J Virol. 2003. PMID: 14610200 Free PMC article.
-
Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.Virology. 2017 Aug;508:90-107. doi: 10.1016/j.virol.2017.04.033. Epub 2017 May 15. Virology. 2017. PMID: 28521215 Free PMC article.
-
Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1.J Virol. 2005 Apr;79(8):4927-35. doi: 10.1128/JVI.79.8.4927-4935.2005. J Virol. 2005. PMID: 15795278 Free PMC article.
-
Fundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages.J Virol. 2010 Sep;84(18):8998-9009. doi: 10.1128/JVI.00996-10. Epub 2010 Jul 7. J Virol. 2010. PMID: 20610711 Free PMC article.
-
Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.J Virol. 2003 Jan;77(1):642-58. doi: 10.1128/jvi.77.1.642-658.2003. J Virol. 2003. PMID: 12477867 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources